Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 291, pseudogene (RN7SL291P)

Target
RN7SL291P
Molecular classification
Other (pseudogene)
01

Overview

RN7SL291P is a pseudogene in the human genome that shares sequence similarity with the functional 7SL RNA gene, which encodes the RNA component of the mammalian signal recognition particle (SRP)[1][3][5][6]. The SRP is essential for directing secretory and membrane proteins to the endoplasmic reticulum during translation. However, RN7SL291P itself does not produce functional RNA or protein, lacks biological activity, and is not known to play any direct role in health or disease[1][3][6]. Pseudogenes like RN7SL291P result from reverse transcription and insertion of RNA back into the genome, leading to truncated and nonfunctional copies of the original gene[3][5]. They are not considered therapeutic targets, biomarkers, or have known safety issues, nor do they interact with drugs or participate in relevant biological pathways. RN7SL291P is a pseudogene, not a receptor, enzyme, transporter, or viable RNA. It has no reported biological or disease function, is not a therapeutic drug target, and has no associated drugs, biomarkers, or safety issues. This entry is correct as a pseudogene, but is incorrect for any therapeutic targeting context.

Other names
RN7SL291P7SL RNA pseudogene

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 291, pseudogene (RN7SL291P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 291, pseudogene (RN7SL291P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call